308 related articles for article (PubMed ID: 7202494)
1. In vivo [3H]spiperone binding to the rat hippocampal formation: involvement of dopamine receptors.
Bischoff S; Bittiger H; Krauss J
Eur J Pharmacol; 1980 Dec; 68(3):305-15. PubMed ID: 7202494
[TBL] [Abstract][Full Text] [Related]
2. Resolution of dopamine and serotonin receptor components of [3H]spiperone binding to rat brain regions.
List SJ; Seeman P
Proc Natl Acad Sci U S A; 1981 Apr; 78(4):2620-4. PubMed ID: 6941314
[TBL] [Abstract][Full Text] [Related]
3. Increase in in vivo (3H) spiperone binding in the rat hippocampal formation and striatum after repeated treatment with haloperidol.
Bischoff S
Experientia; 1981; 37(9):1008-9. PubMed ID: 7297644
[TBL] [Abstract][Full Text] [Related]
4. A comparative study of [3H]haloperidol and [3H]spiroperidol binding to receptors on rat cerebral membranes.
Howlett DR; Nahorski SR
FEBS Lett; 1978 Mar; 87(1):152-6. PubMed ID: 631328
[No Abstract] [Full Text] [Related]
5. [3H]Spiperone binding sites in brain: autoradiographic localization of multiple receptors.
Palacios JM; Niehoff DL; Kuhar MJ
Brain Res; 1981 Jun; 213(2):277-89. PubMed ID: 7248759
[TBL] [Abstract][Full Text] [Related]
6. Quantitative assessment of heterogeneous 3H-spiperone binding to rat neostriatum and frontal cortex.
Howlett DR; Nahorski SR
Life Sci; 1980 Feb; 26(7):511-7. PubMed ID: 7366332
[No Abstract] [Full Text] [Related]
7. Dopaminergic component of [3H]spiroperidol binding in the rat anterior cerebral cortex.
Marchais D; Tassin JP; Bockaert J
Brain Res; 1980 Feb; 183(1):235-40. PubMed ID: 7357406
[No Abstract] [Full Text] [Related]
8. Selective labelling of dopamine (D2) receptors in rat striatum by [3H]domperidone but not by [3H]spiperone.
Lazareno S; Nahorski SR
Eur J Pharmacol; 1982 Jul; 81(2):273-85. PubMed ID: 7117377
[TBL] [Abstract][Full Text] [Related]
9. Analysis of [3H]spiperone binding sites in the rat striatum and frontoparietal cortex by means of quantitative receptor autoradiography after inactivation of dopamine receptors by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline in vivo: selective protection by sulpiride in the striatum.
Fuxe K; Meller E; Goldstein M; Benfenati F; Agnati LF
Neurosci Lett; 1986 Feb; 64(2):163-8. PubMed ID: 3960398
[TBL] [Abstract][Full Text] [Related]
10. Optimal conditions for [3H]apomorphine binding and anomalous equilibrium binding of [3H]apomorphine and [3H]spiperone to rat striatal membranes: involvement of surface phenomena versus multiple binding sites.
Leysen JE; Gommeren W
J Neurochem; 1981 Jan; 36(1):201-19. PubMed ID: 7463046
[TBL] [Abstract][Full Text] [Related]
11. Ontogeny of dopaminergic function in the rat midbrain tegmentum, corpus striatum and frontal cortex.
Noisin EL; Thomas WE
Brain Res; 1988 Jun; 469(1-2):241-52. PubMed ID: 3401800
[TBL] [Abstract][Full Text] [Related]
12. Are striatal [3H]spiperone radioreceptor assays indicative of multiple dopamine receptor interactions?
Clements-Jewery S; Robson PA
Neuropharmacology; 1981 Dec; 20(12B):1295-8. PubMed ID: 7322304
[No Abstract] [Full Text] [Related]
13. 125I-Spiperone: a novel ligand for D2 dopamine receptors.
Gundlach AL; Largent BL; Snyder SH
Life Sci; 1984 Nov; 35(19):1981-8. PubMed ID: 6149442
[TBL] [Abstract][Full Text] [Related]
14. Evidence for loss of brain [3H]spiroperidil and [3H]ADTN binding sites in rabbit brain with aging.
Thal LJ; Horowitz SG; Dvorkin B; Makman MH
Brain Res; 1980 Jun; 192(1):185-94. PubMed ID: 7378779
[TBL] [Abstract][Full Text] [Related]
15. Competitive inhibition of [3H]spiperone binding to D-2 dopamine receptors in striatal homogenates by organic calcium channel antagonists and polyvalent cations.
De Vries DJ; Beart PM
Eur J Pharmacol; 1984 Oct; 106(1):133-9. PubMed ID: 6241565
[TBL] [Abstract][Full Text] [Related]
16. Discrimination of multiple [3H]5-hydroxytryptamine binding sites by the neuroleptic spiperone in rat brain.
Pedigo NW; Yamamura HI; Nelson DL
J Neurochem; 1981 Jan; 36(1):220-6. PubMed ID: 7463047
[TBL] [Abstract][Full Text] [Related]
17. The in vivo and in vitro occupation of [3H]-spiperone binding sites in the frontal cortex and striatum by putative 5-hydroxytryptamine antagonists.
Clements-Jewery S; Robson PA
Neuropharmacology; 1980 Jul; 19(7):657-61. PubMed ID: 7402453
[No Abstract] [Full Text] [Related]
18. In vivo binding of 3H-N-methylspiperone to dopamine and serotonin receptors.
Frost JJ; Smith AC; Kuhar MJ; Dannals RF; Wagner HN
Life Sci; 1987 Mar; 40(10):987-95. PubMed ID: 3821368
[TBL] [Abstract][Full Text] [Related]
19. Quantification of in vivo spiperone binding in the rat striatum after lesions produced by kainate or decortication.
Van der Werf JF; Van het Schip F; Sebens JB; Korf J
Eur J Pharmacol; 1984 Jul; 102(3-4):387-99. PubMed ID: 6436037
[TBL] [Abstract][Full Text] [Related]
20. Dopamine denervation does not alter in vivo 3H-spiperone binding in rat striatum: implications for external imaging of dopamine receptors in Parkinson's disease.
Bennett JP; Wooten GF
Ann Neurol; 1986 Apr; 19(4):378-83. PubMed ID: 3707090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
